CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines

CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines

10.1007/s10549-018-5027-0

Saved in:

Bibliographic Details
Main Authors:	Drogemoller, Britt I, Wright, Galen EB, Shih, Joanne, Monzon, Jose G, Gelmon, Karen A, Ross, Colin JD, Amstutz, Ursula, Carleton, Bruce C, Chang, Wan C, Connolly, Mary B, Dionne, Francois, Groeneweg, Gabriella, Loucks, Catrina M, MacLeod, Stuart M, Pritchard, Sheila, Rassekh, Shahrad R, Sanatani, Shubhayan, Bhavsar, Amit P, Rieder, Michael J, Shear, Neil H, Ito, Shinya, Liu, Geoffrey, Khayat, Philip, Bernstein, Daniel, Lesko, Lawrence J, Aminkeng, Folefac
Other Authors:	MEDICINE
Format:	Review
Language:	English
Published:	SPRINGER 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology Clinical practice guidelines CYP2D6 Pharmacogenomics Systematic review Tamoxifen TAMOXIFEN DOSE-ESCALATION BONE-MINERAL DENSITY ESTROGEN-RECEPTOR POSTMENOPAUSAL WOMEN AROMATASE INHIBITORS ENDOXIFEN CONCENTRATIONS LEVEL METAANALYSIS ACTIVE METABOLITE GENOTYPE THERAPY
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/235040
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Be the first to leave a comment!